Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090707925> ?p ?o ?g. }
- W3090707925 endingPage "15363" @default.
- W3090707925 startingPage "15338" @default.
- W3090707925 abstract "Introduction Cyclic adenosine monophosphate (AMP)-responsive element-binding protein H (CREBH), an endoplasmic reticulum-anchored transcription factor essential for lipid metabolism and inflammation in nonalcoholic fatty liver disease (NAFLD), is covalently modified by N-acetylglucosamine. Glycosylation is a ubiquitous type of protein involved in posttranslational modifications, and plays a critical role in various biological processes. However, the mechanism of glycosylated CREBH remains poorly understood in NAFLD. Methods CREBH glycosylation mutants were obtained by site-mutation methods. After transfection with plasmids, AML-12, LO2, or HepG2 cells were treated with palmitic acid (PA) proteolysis, tunicamycin (Tm), or their combination. Glycosyltransferase V (GnT-V) was used induce hyperglycosylation to further understand the effect of CREBH. In addition, glycosylation mutant mice and hyperglycosylated mice were generated by lentivirus injection to construct two kinds of NAFLD animal models. The expression of NAFLD-related factors was detected to further verify the role of N-linked glycosylation of CREBH in lipid and sterol metabolism, inflammation, and lipotoxicity. Results N-glycosylation enhanced the ability of CREBH to activate transcription and modulated the production of peroxisome proliferator-activated receptor alpha (PPARα) and stearoyl-CoA desaturase-1 (SCD-1) activity by affecting their promoter-driven transcription activity and protein interactions, leading to reduce lipid deposition and attenuate lipotoxicity. Deglycosylation of CREBH induced by Tm could inhibit the proteolysis of CREBH induced by PA. The addition of unglycosylated CREBH to cells upregulates gene and protein expression of lipogenesis, lipotoxicity, and inflammation, and aggravates liver damage by preventing glycosylation in cells, as well as in mouse models of NAFLD. Furthermore, increased N-glycosylation of CREBH, as achieved by overexpressing GnT-V could significantly improve liver lesion caused by unglycosylation of CREBH. Conclusion These findings have important implications for the role of CREBH N-glycosylation in proteolytic activation, and they provide the first link between N-glycosylation of CREBH, lipid metabolism, and lipotoxicity processes in the liver by modulating PPARα and SCD-1. These results provide novel insights into the N-glycosylation of CREBH as a therapeutic target for NAFLD." @default.
- W3090707925 created "2020-10-08" @default.
- W3090707925 creator A5011859684 @default.
- W3090707925 creator A5045069246 @default.
- W3090707925 creator A5054418515 @default.
- W3090707925 creator A5066970334 @default.
- W3090707925 creator A5069516330 @default.
- W3090707925 creator A5076884177 @default.
- W3090707925 creator A5089872052 @default.
- W3090707925 date "2020-09-30" @default.
- W3090707925 modified "2023-10-14" @default.
- W3090707925 title "N‐glycosylation of CREBH improves lipid metabolism and attenuates lipotoxicity in NAFLD by modulating PPARα and SCD‐1" @default.
- W3090707925 cites W1540565773 @default.
- W3090707925 cites W1622799587 @default.
- W3090707925 cites W1965159134 @default.
- W3090707925 cites W1970225752 @default.
- W3090707925 cites W1988805210 @default.
- W3090707925 cites W2003303711 @default.
- W3090707925 cites W2014146744 @default.
- W3090707925 cites W2019694067 @default.
- W3090707925 cites W2026585836 @default.
- W3090707925 cites W2033029728 @default.
- W3090707925 cites W2052780116 @default.
- W3090707925 cites W2053972428 @default.
- W3090707925 cites W2058222111 @default.
- W3090707925 cites W2061774676 @default.
- W3090707925 cites W2063517469 @default.
- W3090707925 cites W2067729127 @default.
- W3090707925 cites W2067740038 @default.
- W3090707925 cites W2075137629 @default.
- W3090707925 cites W2087526887 @default.
- W3090707925 cites W2089198803 @default.
- W3090707925 cites W2090597299 @default.
- W3090707925 cites W2099110406 @default.
- W3090707925 cites W2103525038 @default.
- W3090707925 cites W2130092335 @default.
- W3090707925 cites W2137929725 @default.
- W3090707925 cites W2142835629 @default.
- W3090707925 cites W2143404508 @default.
- W3090707925 cites W2161402141 @default.
- W3090707925 cites W2170539205 @default.
- W3090707925 cites W2203031296 @default.
- W3090707925 cites W2293695674 @default.
- W3090707925 cites W2420348970 @default.
- W3090707925 cites W2433089258 @default.
- W3090707925 cites W2511994840 @default.
- W3090707925 cites W2513051805 @default.
- W3090707925 cites W2522715783 @default.
- W3090707925 cites W2582145734 @default.
- W3090707925 cites W2596989660 @default.
- W3090707925 cites W2606790292 @default.
- W3090707925 cites W2607257154 @default.
- W3090707925 cites W2611406290 @default.
- W3090707925 cites W2612333040 @default.
- W3090707925 cites W2751221443 @default.
- W3090707925 cites W2759997926 @default.
- W3090707925 cites W2767801219 @default.
- W3090707925 cites W2774561112 @default.
- W3090707925 cites W2788179780 @default.
- W3090707925 cites W2788194721 @default.
- W3090707925 cites W2790476182 @default.
- W3090707925 cites W2791716721 @default.
- W3090707925 cites W2792056622 @default.
- W3090707925 cites W2792959572 @default.
- W3090707925 cites W2793414854 @default.
- W3090707925 cites W2924635036 @default.
- W3090707925 cites W3010721885 @default.
- W3090707925 cites W317387912 @default.
- W3090707925 cites W751952818 @default.
- W3090707925 doi "https://doi.org/10.1096/fj.202000836rr" @default.
- W3090707925 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32996649" @default.
- W3090707925 hasPublicationYear "2020" @default.
- W3090707925 type Work @default.
- W3090707925 sameAs 3090707925 @default.
- W3090707925 citedByCount "8" @default.
- W3090707925 countsByYear W30907079252021 @default.
- W3090707925 countsByYear W30907079252022 @default.
- W3090707925 countsByYear W30907079252023 @default.
- W3090707925 crossrefType "journal-article" @default.
- W3090707925 hasAuthorship W3090707925A5011859684 @default.
- W3090707925 hasAuthorship W3090707925A5045069246 @default.
- W3090707925 hasAuthorship W3090707925A5054418515 @default.
- W3090707925 hasAuthorship W3090707925A5066970334 @default.
- W3090707925 hasAuthorship W3090707925A5069516330 @default.
- W3090707925 hasAuthorship W3090707925A5076884177 @default.
- W3090707925 hasAuthorship W3090707925A5089872052 @default.
- W3090707925 hasConcept C126322002 @default.
- W3090707925 hasConcept C134018914 @default.
- W3090707925 hasConcept C170493617 @default.
- W3090707925 hasConcept C185592680 @default.
- W3090707925 hasConcept C187345961 @default.
- W3090707925 hasConcept C2777313579 @default.
- W3090707925 hasConcept C2777391703 @default.
- W3090707925 hasConcept C44353895 @default.
- W3090707925 hasConcept C4733338 @default.
- W3090707925 hasConcept C511355011 @default.
- W3090707925 hasConcept C55493867 @default.
- W3090707925 hasConcept C62231903 @default.